Rocket, Lab

Rocket Lab Faces $800B ETF Buying Wave as Operational Strength Collides With SpaceX Overhang

19.06.2026 - 17:06:30 | boerse-global.de

Rocket Lab's revenue surged 63.5% to $200.3M, backlog hit $2.2B, but stock slid 11% after SpaceX's IPO. Nasdaq-100 inclusion set for June 22 may drive institutional buying.

Rocket Lab Stock: SpaceX IPO Drag, Nasdaq-100 Inclusion, and Neutron Prospects
Rocket - Rocket Lab Faces $800B ETF Buying Wave as Operational Strength Collides With SpaceX Overhang 19.06.2026 - Bild: ĂĽber boerse-global.de

The numbers tell two very different stories about Rocket Lab. Revenue surged 63.5% to $200.3 million in the first quarter, the backlog hit a record $2.2 billion, and the company is about to join the Nasdaq-100. Yet the stock sits roughly 30% below its 52-week high of €133.80, held back by a single event: SpaceX’s public market debut.

That debut on June 12 triggered an immediate 11% plunge in Rocket Lab’s shares, as institutional investors sold smaller space names to free up capital for the new heavyweight. The stock has barely recovered since, and over the past 30 days it has lost roughly 20%. At €93.40, it hovers just above its 50-day moving average — a level that analysts at KeyBanc Capital Markets see as a buying opportunity.

Index inclusion forces institutional buying

The near-term catalyst for a rebound is structural. Starting Monday, June 22, Rocket Lab will officially join the Nasdaq-100 as part of the index’s quarterly rebalancing. More than 200 exchange-traded funds and index funds that track the index — with combined assets under management exceeding $800 billion — will be required to buy the stock. Anyone holding a Nasdaq-100 ETF will automatically own Rocket Lab from that day forward.

The inclusion arrives at a moment when the stock is still digesting the SpaceX overhang. KeyBanc analyst Michael Leshock upgraded Rocket Lab to Overweight from Sector Weight on June 15, setting a price target of $135. He argued the market overreacted to the SpaceX IPO and pointed to rising demand for satellite constellations, growing defense spending in space, and Rocket Lab’s vertical integration model. A setback with the Neutron program in January, he confirmed, has been fully resolved.

Should investors sell immediately? Or is it worth buying Rocket Lab?

Stifel followed with a target increase from $110 to $132, citing strong revenue growth and the expanding backlog.

Neutron remains the pivotal bet

Rocket Lab’s long-term thesis rests on the Neutron rocket, a medium-lift vehicle designed to compete with SpaceX’s Falcon 9 on larger government and commercial missions. The first flight is scheduled for the fourth quarter of 2026, with five commercial contracts already signed. Analysts estimate that at 20 launches per year, Neutron could generate over $1 billion in annual revenue — more than the entire company generated in 2025.

A fuel-tank test failure early this year pushed the debut timeline back, but Rocket Lab has stuck with its Q4 2026 target and is ramping production to as many as four rockets per year. The company argues that SpaceX is increasingly focused on Starlink and Starship, leaving room for Neutron in the midsized launch market.

Defense business provides a floor

While Neutron is still unproven, the defense portfolio is already substantial. Rocket Lab holds an $816 million contract from the U.S. Space Force, a $190 million hypersonic test deal covering 20 launches, and two Space Development Agency contracts worth a combined $1.3 billion. The Space Systems segment now accounts for nearly two-thirds of total revenue.

Operating cash burn improved to $50.3 million in Q1 2026 from $54.2 million a year earlier, and the company ended the quarter with $1.2 billion in cash and no short-term debt.

Rocket Lab at a turning point? This analysis reveals what investors need to know now.

Fresh mission and quarterly guidance

On the launch side, Rocket Lab postponed its 90th Electron mission — dubbed “Ten Owl Of Ten” — for additional pre-flight checks. That flight, carrying a SAR satellite for Japanese earth-observation firm Synspective to a 552-kilometer orbit, is now expected to lift off in June. It would be the tenth dedicated launch for Synspective, Rocket Lab’s only continuous customer since 2020.

For the second quarter, management has guided for revenue between $225 million and $240 million. Earnings are due in August. By then, the index buying will already be flowing, and the market will have a clearer read on whether Rocket Lab’s operational momentum can finally shake off the shadow of its giant competitor.

Ad

Rocket Lab Stock: New Analysis - 19 June

Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Rocket Lab analysis...

en | US7731211089 | ROCKET | boerse | 69583594 |